Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

XiVE S plus Impl D4.5/L9.5: medical device reports filed with FDA

2,944 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

2,944
device reports naming the brand
0% of all MAUDE reports · about 416 a year
324
reports, 12 months to August 2026
458 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

2,944 medical device reports received by FDA name the brand "XiVE S plus Impl D4.5/L9.5" (implant endosseous root-form); the manufacturer given most often on reports is Dentsply Implants Manufacturing; received from June 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

324 reports arrived in the 12 months to August 2026, down 29% from 458 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (43.3%), loss of osseointegration (29.9%) and osseointegration problem (26.3%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

03978Sep 2021: 24Oct 2021: 38Nov 2021: 47Dec 2021: 422022Jan 2022: 29Feb 2022: 64Mar 2022: 32Apr 2022: 40May 2022: 46Jun 2022: 60Jul 2022: 35Aug 2022: 78Sep 2022: 42Oct 2022: 38Nov 2022: 57Dec 2022: 442023Jan 2023: 36Feb 2023: 49Mar 2023: 44Apr 2023: 64May 2023: 54Jun 2023: 47Jul 2023: 53Aug 2023: 29Sep 2023: 40Oct 2023: 26Nov 2023: 44Dec 2023: 332024Jan 2024: 41Feb 2024: 46Mar 2024: 43Apr 2024: 57May 2024: 55Jun 2024: 53Jul 2024: 39Aug 2024: 68Sep 2024: 52Oct 2024: 47Nov 2024: 45Dec 2024: 172025Jan 2025: 40Feb 2025: 30Mar 2025: 70Apr 2025: 19May 2025: 38Jun 2025: 27Jul 2025: 38Aug 2025: 35Sep 2025: 48Oct 2025: 20Nov 2025: 25Dec 2025: 342026Jan 2026: 42Feb 2026: 27Mar 2026: 27Apr 2026: 26May 2026: 24Jun 2026: 21Jul 2026: 15Aug 2026: 15

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03196372019: 3920192021: 63720212022: 56520222023: 51920232024: 56320242025: 42420252026: 1972026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,944
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%2,944
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,27543.3%62.8%
Loss of osseointegration88129.9%22.4%
Osseointegration problem77326.3%7.7%
Fracturea broken bone180.6%1.6%
Malposition of device20.1%0.1%
Improper or incorrect procedure or method10%0%
Insufficient device problem information10%0.2%
Loosening of implant not related to bone-ingrowth10%0.1%
Overfill10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant2,94299.9%
Inflammationinflammation38413%
Osteolysis1465%
Pocket erosion1003.4%
Implant pain50.2%
Inadequate osseointegration30.1%
Deformity/ disfigurement20.1%
Painpain, site not specified20.1%
Hypoesthesia10%
Laceration(s)10%
Sinus perforation10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureXiVE S plus Impl D4.5/L9.5Product code DZEAll MAUDE reports
Reports2,9443,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about XiVE S plus Impl D4.5/L9.5 reports

How many FDA reports name XiVE S plus Impl D4.5/L9.5?

2,944 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 324 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (43.3%), loss of osseointegration (29.9%), osseointegration problem (26.3%), fracture (0.6%) and malposition of device (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that XiVE S plus Impl D4.5/L9.5 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.